undamentalytics Newsletter

Oramed Pharmaceuticals Inc. valuation and forecast

Explore the models for Oramed Pharmaceuticals Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Price history

Loading chart…

Third-party market data · may be delayed

ORMP valuation questions

How does Fundamentalytics value Oramed Pharmaceuticals Inc.?
We use the models that fit Oramed Pharmaceuticals Inc.'s business and available financial data: residual income, justified price-to-book. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Oramed Pharmaceuticals Inc.

Compare with peers